A review published in JAMA Network Open examined how social media influencers shape what people learn about and how they approach prescription medications, and found that influencer…
A large observational analysis of U.S. health records suggests that long-term use of some drugs prescribed for irritable bowel syndrome (IBS) is associated with a small but…
The Food and Drug Administration has approved leucovorin for treating cerebral folate transport deficiency caused by FOLR1 variants, a rare neurological condition marked by low folate…
A February 2026 ADAP Watch report from the National Association of State and Territorial AIDS Directors (NASTAD) finds that multiple states are cutting or restricting programs that…
Use of GLP-1 medications for weight loss has ballooned in recent years; a Kaiser Family Foundation poll found about one in eight adults reported trying a GLP-1 drug.
Thousands of men with non-metastatic prostate cancer will be offered the drug abiraterone on the NHS in England within weeks.
A large analysis published October 21 in The Lancet examined more than 58,000 people across 151 trials of 30 commonly prescribed antidepressants during the first eight weeks of…
The FDA has approved a generic version of mifepristone — the 200 mg tablet used with misoprostol for medication abortion through 70 days’ gestation.
When Celtics forward Jayson Tatum ruptured his Achilles tendon on May 12 during the Eastern Conference playoff game against the New York Knicks, he immediately sensed something was…
The FDA plans to notify clinicians about a possible link between prenatal acetaminophen (Tylenol) use and higher rates of neurodevelopmental conditions such as autism and ADHD.
A recent study suggests that GLP-1 weight-loss medications such as semaglutide (the active agent in Ozempic and Wegovy) may produce smaller or shorter-lived benefits for people whose…